Effects of pure eicosapentaenoic and docosahexaenoic acids on oxidative stress, inflammation and body fat mass in patients with type 2 diabetes

International Journal of Preventive Medicine

Volumn 4, Issue 8, 2013, Pages 922-928

  Azizi Soleiman, Fatemeh ^a   Jazayeri, Shima ^a   Eghtesadi, Shahryar ^a   Rajab, Asadollah ^d   Heidari, Iraj ^c   Vafa, Mohammad R ^a   Gohari, Mahmood R ^b  

^a School of Public Health   (Iran)

^b School of Management and Medical Information   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Iranian Diabetes Society   (Iran)

Author keywords

Inflammation; Omega 3 fatty acids; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

BIGUANIDE DERIVATIVE; C REACTIVE PROTEIN; CANOLA OIL; DOCOSAHEXAENOIC ACID; GLICLAZIDE; GLUCOSE; ICOSAPENTAENOIC ACID; MALONALDEHYDE; PLACEBO; SULFONYLUREA; TOCOPHEROL; TRACE ELEMENT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DRUG ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; ENERGY; ENTEROPATHY; FAT MASS; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIPLE BLIND PROCEDURE;

EID: 84884133056     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Torp-PedersenC,Rask-MadsenC,GustafssonI,GustafssonF, Kober L. Diabetes mellitus and cardiovascular risk: Just another risk factor? Eur Heart J Suppl 2003;5(suppl F): F26-32.
2. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793-801.
3. de Rekeneire N, Peila R, Ding J, Colbert LH, Visser M, Shorr RI, et al. Diabetes, hyperglycemia, and inflammation in older individuals. Diabetes Care 2006;29:1902-8.
4. Kraja AT, Province MA, Arnett D, Wagenknecht L, Tang W, Hopkins PN, et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster. Nutr Metab 2007;21:28.
5. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9.
6. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: Insights from mechanistic studies. Lancet 2008;371:1800-9.
7. Goycheva PGVPB. Oxidative stress and its compplications in diabetes mellitus. Trakia J Sci 2006;4:1-8.
8. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review. J Am Diet Assoc 2005;105:428-40.
9. Barre DE. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes-a mini-review. J Oleo Sci 2007;56:319-25.
10. Verlengia R, Gorjão R, Kanunfre CC, Bordin S, De Lima TM, Fernandes Martins E, et al. Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells. Lipids 2004;39:857-64.
11. Sarbolouki SH, Djalali M, Dorosty AR, Djazayery SA, Eshraghian M., Ebadi SAR, et al. Effects of EPA and vitamin E on serum enzymatic antioxidants and peroxidation indices in patients with type II diabetes mellitus. Iranian J Public Health 2010;39:82-91.
12. Pooya Sh DM, Djazayery A, Saedisomeolia A, Eshraghian M., Toorang F. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2010;20:326-31.
13. Kesavulu MM, Kameswararao B, Apparao C, Kumar EG, Harinarayan CV. Effect of n-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab 2002;28:20-6.
14. Puhakainen I, Ahola I, Yki-Jarvinen H. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non- insulin-dependent diabetes mellitus. Am J Clin Nutr 1995;61:121-6.
15. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.
16. Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S. Effects of omega-3 fatty acids on serum lipids, apolipoproteins and malondialehyde in typ 2 diabetes patients. East Mediterr Health J 2008;14:305-13.
17. Nyby MD, Matsumoto K, Yamamoto K,Abedi K, Eslami P, Hernandez G, et al. Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am J Hypertens 2005;18:213-9.
18. Shidfar F, Keshavarz A, Jallali M, Miri R, Eshraghian M. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-1, apo B, and malondialdehyde in hyperlipidemic patients. Int J Vitam Nutr Res 2003;73:163-70.
19. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003;35:772-81.
20. Wong CY, Yiu KH, Li SW, Lee S, Tam S, Lau CP, et al. Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with type 2 diabetes mellitus. Diabet Med 2010;27:54-60.
21. Nakhjavani M, Esteghamati A, Nowroozi S, Asgarani F, Rashidi A, Khalilzadeh O. Type 2 diabetes mellitus duration: An independent predictor of serum malondialdehyde levels. Singapore Med J 2010;51:582-5.
22. Soliman GZ. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 2008;49:129-36.
23. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134:2991-7.
24. Plat J, Jellema A, Ramakers J, Mensink RP. Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr 2007;137:2635-40.
25. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: Reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006;84:540-50.
26. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: A randomized controlled study. Am J Clin Nutr 2007;86:1670-9.